Starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days of seeking treatment is more effective than the standard treatment method of starting within 10–15 days, but requires closer medical supervision, according to results from a clinical trial published in JAMA Network Open.
Medical Xpress – latest medical and health news stories
